Bionomics Ltd - Prakiraan wutah bathi resik saben saham kanggo taun ngarep BNOX

Logo korporat perusahaan Bionomics (BNOX)

Bionomics Limited is optimizing costs by outsourcing production and testing to third-party contractors. The expected EPS trend for the coming year reflects the current analyst consensus, with the latest value recorded as 31.70. Bionomics Limited aims to expand the BNC210 drug through B2B partnerships in neurology. The primary growth triggers will be the results of PTSD treatment trials, while current quotes already price in development expenses.

Bionomics Ltd (BNOX): Prakiraan wutah bathi resik saben saham kanggo taun ngarep saka 04.07.2022 nganti 24.12.2024

Ringkesan rincian data analitis Bionomics (BNOX)

- rega lan prakiraan konsensus rega:
Analisis fundamental perusahaan:Bionomics Limited, BNOX
Produk dadi Bionomics Ltd

The retention of key competencies among Australian neurologists and their regulatory potential determine the current growth forecast for Bionomics Limited (BNOX) earnings per share. This metric aggregates analyst consensus estimates for next year's EPS dynamics, measuring the expected efficiency of capitalizing on clinical successes, which allows investors to assess the probability of the company transitioning from the development stage to actual profit generation.

Pesaing wigati

Prakiraan wutah bathi resik saben saham kanggo taun ngarep Jazz Pharma|CYTK: Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep PTC Therapeutics, Inc. (PTCT)|SRRK - Prakiraan wutah bathi resik saben saham ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Centessa CNTA|Dyne Therapeutics Inc - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|EWTX - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Rapport Corp|ALMS: Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep zevra.com ZVRA|Prakiraan wutah bathi saben saham kanggo taun ngarep CTNM|Prakiraan wutah bathi resik saben saham ing taun ngarep Larimar Therapeutics Inc LRMR|Prakiraan wutah bathi kanggo taun ngarep CAPR|Prakiraan wutah bathi resik saben saham kanggo taun ngarep TRDA (Entrada Therapeutics, Inc)|Prakiraan wutah bathi kanggo taun ngarep PTHS (Channel Therapeutics)|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep MediciNova Inc. (MNOV)|SER - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep BioXcel Therapeutics Inc|promisneurosciences.com (PMN) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep APUS|Prakiraan wutah bathi resik saben saham kanggo taun ngarep AEON Biopharma Inc.|Prakiraan wutah bathi resik saben saham ing taun ngarep NLS Pharma NLSP|Prakiraan wutah bathi resik saben saham kanggo taun ngarep FSD Pharma (HUGE)|Prakiraan wutah bathi saben saham kanggo taun ngarep Reata Pharmaceuticals Inc RETA